SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-079669
Filing Date
2024-07-01
Accepted
2024-07-01 16:30:10
Documents
11
Period of Report
2024-06-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K aktx-20240628.htm   iXBRL 8-K 83131
  Complete submission text file 0000950170-24-079669.txt   307800

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aktx-20240628.xsd EX-101.SCH 97668
13 EXTRACTED XBRL INSTANCE DOCUMENT aktx-20240628_htm.xml XML 6056
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 8-K | Act: 34 | File No.: 001-36288 | Film No.: 241091043
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)